Cardinal Health, Inc.

NYSE:CAH

Medical - Distribution

Healthcare
$278.32 -1.66%

-$3.77 today

Market cap
$64.33B
Beta
0.53
P/E (TTM)
33.5
EPS (TTM)
$6.63
Dividend yield
0.92%
52W Low $137.75High $233.60

Volume 1.35M

Average 2.11M

CAH EBITDA Margin

EBITDA as a percentage of revenue.

Cardinal Health, Inc.NYSE: CAH

EBITDA Margin · Q1 FY2027 · quarter ended Sep 2026

EBITDA Margin holds steady near 1.5%

EBITDA Margin was 1.5% in Q1 FY2027, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 1.4%, down 0.0 pp year over year. Over 3 fiscal years it widened by 0.7 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 1.9% for the fiscal year ending Jun 2027, up from 1.4% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
1.5%-0.2 pp QoQ
Last fiscal yearJun 2026
1.4%-0.0 pp YoY
LTMSep 2026
1.4%-0.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.1 pp+0.7 pp+0.7 pp
1 year-0.0 pp+0.6 pp+0.6 pp
3 years+0.7 pp+0.6 pp-0.1 pp
5 years+1.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
1.4%
Year-over-year change
-0.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How CAH compares with its peers on the latest reported figures

  • CAH's LTM Sep 2026 EBITDA Margin of 1.4% is the lowest of the 4 companies compared; the peer median is 1.8%.
  • Its year-over-year change of -0.0 pp is the lowest of 4, against a peer median of +0.3 pp.
  • Over three fiscal years its change of +0.7 pp compares with a peer median of -0.1 pp.
CAH Competitors Peer median
EBITDA Margin for CAH and competitors
Company Period LTM level YoY 3-year change
HSICHenry Schein, Inc.LTM Jun 20267.7% +0.2 pp-0.1 pp
MCKMcKesson CorporationLTM Jun 20261.8% +0.4 pp-0.2 pp
CORCencora, Inc.LTM Jun 20261.5% +0.3 pp-0.1 pp
CAHCardinal Health, Inc.LTM Sep 20261.4% -0.0 pp+0.7 pp
Peer median (excluding CAH) 1.8%+0.3 pp-0.1 pp

Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue181.33B204.98B226.83B222.58B254.25B
Cost of Revenue174.84B198.11B219.41B214.41B244.47B
Gross Profit6.48B6.89B7.41B8.17B9.77B
Gross Margin3.6%3.4%3.3%3.7%3.8%
Research & Development00000
Selling, General & Admin4.51B4.8B5B5.38B6.13B
Operating Expenses7.09B6.12B6.17B5.89B7.16B
Depreciation & Amortization692M692M710M790M956M
EBITDA55M1.44B1.96B3.11B3.48B
EBITDA Margin0.0%0.7%0.9%1.4%1.4%
Operating Income(607M)752M1.24B2.28B2.61B
Operating Margin-0.3%0.4%0.5%1.0%1.0%
Interest Income00000
Interest Expense147M84M51M215M348M
Other Income / Expenses(177M)(89M)(42M)(174M)(439M)
Income Before Tax(784M)663M1.2B2.1B2.17B
Pre-Tax Margin-0.4%0.3%0.5%0.9%0.9%
Income Tax Expense153M332M348M532M469M
Net Income(938M)330M852M1.56B1.71B
Net Margin-0.5%0.2%0.4%0.7%0.7%
EPS (Basic)(3.34)1.263.486.487.27
EPS (Diluted)(3.34)1.263.456.457.23
Weighted Avg Shares279M261M245M241M236M
Weighted Avg Shares (Diluted)279M262M247M242M237M

Cardinal Health, Inc.

NYSE:CAH

Intrinsic Alpha fair value

Locked

Current Price

$278.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.